Gene Symbol | NOS3 |
Entrez ID | 4846 |
Uniprot ID | P29474 |
Description | nitric oxide synthase 3 |
Chromosomal Location | chr7: 150,990,995-151,014,588 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0001525 |
angiogenesis |
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels. |
IEA |
BP |
GO:0001542 |
ovulation from ovarian follicle |
The process leading to the rupture of the follicle, releasing the centrally located oocyte into the oviduct. An example of this is found in Mus musculus. |
IEA |
BP |
GO:0001701 |
in utero embryonic development |
The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus. |
IEA |
BP |
GO:0001974 |
blood vessel remodeling |
The reorganization or renovation of existing blood vessels. |
ISS |
BP |
GO:0002028 |
regulation of sodium ion transport |
Any process that modulates the frequency, rate or extent of the directed movement of sodium ions (Na+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
IEA |
BP |
GO:0003057 |
regulation of the force of heart contraction by chemical signal |
The regulation of the force of heart muscle contraction mediated by chemical signaling, hormonal, autocrine or paracrine. |
IEA |
BP |
GO:0003100 |
regulation of systemic arterial blood pressure by endothelin |
The process in which endothelin modulates the force with which blood passes through the circulatory system. Endothelin is a hormone that is released by the endothelium, and it is a vasoconstrictor. |
IMP |
BP |
GO:0006527 |
arginine catabolic process |
The chemical reactions and pathways resulting in the breakdown of arginine, 2-amino-5-(carbamimidamido)pentanoic acid. |
IDA |
BP |
GO:0006809 |
nitric oxide biosynthetic process |
The chemical reactions and pathways resulting in the formation of nitric oxide, nitrogen monoxide (NO), a colorless gas only slightly soluble in water. |
IDA |
BP |
GO:0007005 |
mitochondrion organization |
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a mitochondrion; includes mitochondrial morphogenesis and distribution, and replication of the mitochondrial genome as well as synthesis of new mitochondrial components. |
ISS |
BP |
GO:0007263 |
nitric oxide mediated signal transduction |
Any intracellular signal transduction in which the signal is passed on within the cell via nitric oxide (NO). Includes synthesis of nitric oxide, receptors/sensors for nitric oxide (such as soluble guanylyl cyclase/sGC) and downstream effectors that further transmit the signal within the cell. Nitric oxide transmits its downstream effects through either cyclic GMP (cGMP)-dependent or independent mechanisms. |
IBA |
BP |
GO:0008217 |
regulation of blood pressure |
Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure. |
NAS |
BP |
GO:0008285 |
negative regulation of cell proliferation |
Any process that stops, prevents or reduces the rate or extent of cell proliferation. |
ISS |
BP |
GO:0009408 |
response to heat |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism. |
NAS |
BP |
GO:0010544 |
negative regulation of platelet activation |
Any process that decreases the rate or frequency of platelet activation. Platelet activation is a series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. |
NAS |
BP |
GO:0014740 |
negative regulation of muscle hyperplasia |
Any process that stops, prevents, or reduces the frequency, rate, or extent of muscle hyperplasia. |
ISS |
BP |
GO:0014806 |
smooth muscle hyperplasia |
A process, occurring in smooth muscle, in which there is an increase in cell number by cell division, often leading to an increase in the size of an organ. |
ISS |
BP |
GO:0019430 |
removal of superoxide radicals |
Any process, acting at the cellular level, involved in removing superoxide radicals (O2-) from a cell or organism, e.g. by conversion to dioxygen (O2) and hydrogen peroxide (H2O2). |
IDA |
BP |
GO:0030324 |
lung development |
The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax. |
IEA |
BP |
GO:0031284 |
positive regulation of guanylate cyclase activity |
Any process that activates or increases the frequency, rate or extent of guanylate cyclase activity. |
IMP|ISS |
BP |
GO:0031663 |
lipopolysaccharide-mediated signaling pathway |
A series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system. |
IEA |
BP |
GO:0034405 |
response to fluid shear stress |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fluid shear stress stimulus. Fluid shear stress is the force acting on an object in a system where the fluid is moving across a solid surface. |
IEP |
BP |
GO:0043267 |
negative regulation of potassium ion transport |
Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of potassium ions (K+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
IEA |
BP |
GO:0043542 |
endothelial cell migration |
The orderly movement of an endothelial cell into the extracellular matrix to form an endothelium. |
IMP |
BP |
GO:0045454 |
cell redox homeostasis |
Any process that maintains the redox environment of a cell or compartment within a cell. |
TAS |
BP |
GO:0045766 |
positive regulation of angiogenesis |
Any process that activates or increases angiogenesis. |
ISS |
BP |
GO:0045776 |
negative regulation of blood pressure |
Any process in which the force of blood traveling through the circulatory system is decreased. |
IBA |
BP |
GO:0045909 |
positive regulation of vasodilation |
Any process that activates or increases the frequency, rate or extent of vasodilation. |
IBA|NAS |
BP |
GO:0050880 |
regulation of blood vessel size |
Any process that modulates the size of blood vessels. |
ISS|NAS |
BP |
GO:0050999 |
regulation of nitric-oxide synthase activity |
Any process that modulates the activity of the enzyme nitric-oxide synthase. |
TAS |
BP |
GO:0051346 |
negative regulation of hydrolase activity |
Any process that stops or reduces the rate of hydrolase activity, the catalysis of the hydrolysis of various bonds. |
IEA |
BP |
GO:0051926 |
negative regulation of calcium ion transport |
Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of calcium ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
IEA |
BP |
GO:0055114 |
oxidation-reduction process |
A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons. |
IEA |
BP |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors. |
ISS |
CC |
GO:0000139 |
Golgi membrane |
The lipid bilayer surrounding any of the compartments of the Golgi apparatus. |
TAS |
CC |
GO:0005634 |
nucleus |
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
ISS |
CC |
GO:0005737 |
cytoplasm |
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
IDA |
CC |
GO:0005829 |
cytosol |
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
TAS |
CC |
GO:0005856 |
cytoskeleton |
Any of the various filamentous elements that form the internal framework of cells, and typically remain after treatment of the cells with mild detergent to remove membrane constituents and soluble components of the cytoplasm. The term embraces intermediate filaments, microfilaments, microtubules, the microtrabecular lattice, and other structures characterized by a polymeric filamentous nature and long-range order within the cell. The various elements of the cytoskeleton not only serve in the maintenance of cellular shape but also have roles in other cellular functions, including cellular movement, cell division, endocytosis, and movement of organelles. |
IEA |
CC |
GO:0005886 |
plasma membrane |
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
TAS |
CC |
GO:0005901 |
caveola |
A membrane raft that forms small pit, depression, or invagination that communicates with the outside of a cell and extends inward, indenting the cytoplasm and the cell membrane. Examples include flask-shaped invaginations of the plasma membrane in adipocytes associated with caveolin proteins, and minute pits or incuppings of the cell membrane formed during pinocytosis. Caveolae may be pinched off to form free vesicles within the cytoplasm. |
IDA |
CC |
GO:0030666 |
endocytic vesicle membrane |
The lipid bilayer surrounding an endocytic vesicle. |
TAS |
MF |
GO:0003785 |
actin monomer binding |
Interacting selectively and non-covalently with monomeric actin, also known as G-actin. |
IPI |
MF |
GO:0004517 |
nitric-oxide synthase activity |
Catalysis of the reaction: L-arginine + n NADPH + n H+ + m O2 = citrulline + nitric oxide + n NADP+. |
IDA|IMP|TAS |
MF |
GO:0005506 |
iron ion binding |
Interacting selectively and non-covalently with iron (Fe) ions. |
IEA |
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
MF |
GO:0005516 |
calmodulin binding |
Interacting selectively and non-covalently with calmodulin, a calcium-binding protein with many roles, both in the calcium-bound and calcium-free states. |
IEA |
MF |
GO:0010181 |
FMN binding |
Interacting selectively and non-covalently with flavin mono nucleotide. Flavin mono nucleotide (FMN) is the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes. |
NAS |
MF |
GO:0020037 |
heme binding |
Interacting selectively and non-covalently with heme, any compound of iron complexed in a porphyrin (tetrapyrrole) ring. |
IDA |
MF |
GO:0034617 |
tetrahydrobiopterin binding |
Interacting selectively and non-covalently with a tetrahydrobiopterin, 5,6,7,8-tetrahydrobiopterin or a derivative thereof; tetrahydrobiopterins are enzyme cofactors that carry electrons in redox reactions. |
IDA |
MF |
GO:0034618 |
arginine binding |
Interacting selectively and non-covalently with 2-amino-5-(carbamimidamido)pentanoic acid. |
IDA |
MF |
GO:0046870 |
cadmium ion binding |
Interacting selectively and non-covalently with cadmium (Cd) ions. |
NAS |
MF |
GO:0050660 |
flavin adenine dinucleotide binding |
Interacting selectively and non-covalently with FAD, flavin-adenine dinucleotide, the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes, in either the oxidized form, FAD, or the reduced form, FADH2. |
NAS |
MF |
GO:0050661 |
NADP binding |
Interacting selectively and non-covalently with nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions; binding may be to either the oxidized form, NADP+, or the reduced form, NADPH. |
NAS |
MF |
GO:0097110 |
scaffold protein binding |
Interacting selectively and non-covalently with a scaffold protein. Scaffold proteins are crucial regulators of many key signaling pathways. Although not strictly defined in function, they are known to interact and/or bind with multiple members of a signaling pathway, tethering them into complexes. |
IEA |
Domain ID | Description |
---|---|
IPR001094 |
Flavodoxin-like |
IPR001433 |
Oxidoreductase FAD/NAD(P)-binding |
IPR001709 |
Flavoprotein pyridine nucleotide cytochrome reductase |
IPR003097 |
FAD-binding, type 1 |
IPR004030 |
Nitric oxide synthase, N-terminal |
IPR008254 |
Flavodoxin/nitric oxide synthase |
IPR012144 |
Nitric-oxide synthase, eukaryote |
IPR017927 |
Ferredoxin reductase-type FAD-binding domain |
IPR017938 |
Riboflavin synthase-like beta-barrel |
IPR029039 |
Flavoprotein-like domain |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa00220 |
Arginine biosynthesis |
KEGG |
hsa00330 |
Arginine and proline metabolism |
KEGG |
hsa01100 |
Metabolic pathways |
KEGG |
hsa04020 |
Calcium signaling pathway |
KEGG |
hsa04022 |
cGMP-PKG signaling pathway |
KEGG |
hsa04066 |
HIF-1 signaling pathway |
KEGG |
hsa04071 |
Sphingolipid signaling pathway |
KEGG |
hsa04151 |
PI3K-Akt signaling pathway |
KEGG |
hsa04370 |
VEGF signaling pathway |
KEGG |
hsa04371 |
Apelin signaling pathway |
KEGG |
hsa04611 |
Platelet activation |
KEGG |
hsa04915 |
Estrogen signaling pathway |
KEGG |
hsa04921 |
Oxytocin signaling pathway |
KEGG |
hsa04931 |
Insulin resistance |
KEGG |
hsa04933 |
AGE-RAGE signaling pathway in diabetic complications |
KEGG |
hsa05418 |
Fluid shear stress and atherosclerosis |
KEGG |
WP437 |
EGF/EGFR Signaling Pathway |
WikiPathways |
WP2324 |
AGE/RAGE pathway |
WikiPathways |
WP2355 |
Corticotropin-releasing hormone signaling pathway |
WikiPathways |
WP3844 |
PI3K-AKT-mTOR signaling pathway and therapeutic opportunities |
WikiPathways |
WP289 |
Myometrial Relaxation and Contraction Pathways |
WikiPathways |
WP2034 |
Leptin signaling pathway |
WikiPathways |
WP1539 |
Angiogenesis |
WikiPathways |
WP2197 |
Endothelin Pathways |
WikiPathways |
WP1995 |
Effects of Nitric Oxide |
WikiPathways |
WP554 |
ACE Inhibitor Pathway |
WikiPathways |
WP3932 |
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway |
WikiPathways |
WP3888 |
VEGFA-VEGFR2 Signaling Pathway |
WikiPathways |
h_no1Pathway |
Actions of Nitric Oxide in the Heart |
BioCarta |
h_gcrPathway |
Corticosteroids and cardioprotection |
BioCarta |
h_hifPathway |
Hypoxia-Inducible Factor in the Cardiovascular System |
BioCarta |
h_raccPathway |
Ion Channels and Their Functional Role in Vascular Endothelium |
BioCarta |
h_vegfPathway |
VEGF, Hypoxia, and Angiogenesis |
BioCarta |
UMLS CUI | UMLS Term |
---|---|
C0000832 |
Abruptio Placentae |
C0001418 |
Adenocarcinoma |
C0002395 |
Alzheimer'S Disease |
C0003130 |
Anoxia |
C0003850 |
Arteriosclerosis |
C0004153 |
Atherosclerosis |
C0004238 |
Atrial Fibrillation |
C0007222 |
Cardiovascular Diseases |
C0007785 |
Cerebral Infarction |
C0008924 |
Cleft Lip |
C0008925 |
Cleft Palate |
C0010073 |
Coronary Artery Vasospasm |
C0011853 |
Diabetes Mellitus, Experimental |
C0011854 |
Diabetes Mellitus, Insulin-Dependent |
C0011860 |
Diabetes Mellitus, Non-Insulin-Dependent |
C0011875 |
Diabetic Angiopathies |
C0011881 |
Diabetic Nephropathy |
C0014859 |
Esophageal Neoplasms |
C0015934 |
Fetal Growth Retardation |
C0018800 |
Cardiomegaly |
C0018801 |
Heart Failure |
C0019284 |
Diaphragmatic Hernia |
C0020456 |
Hyperglycemia |
C0020459 |
Hyperinsulinism |
C0020473 |
Hyperlipidemia |
C0020538 |
Hypertensive Disease |
C0020541 |
Hypertension, Portal |
C0020542 |
Pulmonary Hypertension |
C0020545 |
Hypertension, Renovascular |
C0021364 |
Male Infertility |
C0021655 |
Insulin Resistance |
C0021845 |
Intestinal Perforation |
C0022116 |
Ischemia |
C0023893 |
Liver Cirrhosis, Experimental |
C0024117 |
Chronic Obstructive Airway Disease |
C0027051 |
Myocardial Infarction |
C0027055 |
Myocardial Reperfusion Injury |
C0032914 |
Pre-Eclampsia |
C0033578 |
Prostatic Neoplasms |
C0034063 |
Pulmonary Edema |
C0035126 |
Reperfusion Injury |
C0038356 |
Stomach Neoplasms |
C0038358 |
Gastric Ulcer |
C0041948 |
Uremia |
C0042514 |
Tachycardia, Ventricular |
C0042594 |
Vestibular Diseases |
C0151636 |
Premature Ventricular Contractions |
C0151744 |
Myocardial Ischemia |
C0242350 |
Erectile Dysfunction |
C0243026 |
Sepsis |
C0520459 |
Necrotizing Enterocolitis |
C0524620 |
Metabolic Syndrome X |
C0852036 |
Pregnancy Associated Hypertension |
C1458155 |
Mammary Neoplasms |
C1956346 |
Coronary Artery Disease |
C2609414 |
Acute Kidney Injury |
Tissue | Cell Type |
---|---|
placenta |
trophoblastic cells |
Database Name |
---|
DisGeNET |
DGA |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
PLCG1 |
5335 |
P19174 |
0.00 |
PLCG2 |
5336 |
P16885 |
0.00 |
PRKAA2 |
5563 |
P54646 |
0.00 |
PRKCD |
5580 |
Q05655 |
0.00 |
RAC2 |
5880 |
P15153 |
0.00 |
ROCK1 |
6093 |
Q13464 |
0.00 |
SRC |
6714 |
P12931 |
0.00 |
TGFBR1 |
7046 |
P36897 |
0.00 |
TGFBR2 |
7048 |
P37173 |
0.00 |
ROCK2 |
9475 |
O75116 |
0.00 |
AGTR1 |
185 |
P30556 |
0.52 |
BDNF |
627 |
P23560 |
0.52 |
BDKRB2 |
624 |
P30411 |
0.62 |
A2M |
2 |
P01023 |
0.63 |
CAMK2A |
815 |
Q9UQM7 |
0.63 |
CTNNB1 |
1499 |
P35222 |
0.63 |
ELAVL1 |
1994 |
Q15717 |
0.63 |
H3F3A; H3F3B |
3020 |
P84243 |
0.63 |
PSEN2 |
5664 |
P49810 |
0.63 |
UMPS |
7372 |
P11172 |
0.63 |
TECR |
9524 |
Q9NZ01 |
0.63 |
PAXIP1 |
22976 |
Q6ZW49 |
0.63 |
EFEMP2 |
30008 |
O95967 |
0.63 |
EXOSC1 |
51013 |
Q9Y3B2 |
0.63 |
CEP55 |
55165 |
Q53EZ4 |
0.63 |
RNF32 |
140545 |
Q9H0A6 |
0.63 |
ACTB |
60 |
P60709 |
0.68 |
APP |
351 |
P05067 |
0.72 |
GCDH |
2639 |
Q92947 |
0.77 |
NOS3 |
4846 |
P29474 |
0.89 |
HSP90AA1 |
3320 |
P07900 |
0.90 |
CALML3 |
810 |
P27482 |
0.00 |
NOS1 |
4842 |
P29475 |
0.00 |
EDNRB |
1910 |
P24530 |
0.52 |
NMT1 |
4836 |
P30419 |
0.52 |
SP1 |
6667 |
P08047 |
0.55 |
PPP2R5A |
5525 |
Q15172 |
0.62 |
ACTN4 |
81 |
O43707 |
0.63 |
ACTN2 |
88 |
P35609 |
0.63 |
ELAVL3 |
1995 |
Q14576 |
0.63 |
ESR1 |
2099 |
P03372 |
0.63 |
EFEMP1 |
2202 |
Q12805 |
0.63 |
GOLGA2 |
2801 |
Q08379 |
0.63 |
MAGEA11 |
4110 |
P43364 |
0.63 |
HTRA1 |
5654 |
Q92743 |
0.63 |
PSEN1 |
5663 |
P49768 |
0.63 |
HDAC3 |
8841 |
O15379 |
0.63 |
IMMT |
10989 |
Q16891 |
0.63 |
MAST1 |
22983 |
Q9Y2H9 |
0.63 |
MPRIP |
23164 |
Q6WCQ1 |
0.63 |
SIRT1 |
23411 |
Q96EB6 |
0.63 |
KANK2 |
25959 |
Q63ZY3 |
0.63 |
FIS1 |
51024 |
Q9Y3D6 |
0.63 |
TXNDC11 |
51061 |
Q6PKC3 |
0.63 |
EXOC6 |
54536 |
Q8TAG9 |
0.63 |
RNF31 |
55072 |
Q96EP0 |
0.63 |
PI4K2A |
55361 |
Q9BTU6 |
0.63 |
APOE |
348 |
P02649 |
0.68 |
ST13 |
6767 |
P50502 |
0.76 |
CDC37 |
11140 |
Q16543 |
0.77 |
GUCY1B3 |
2983 |
Q02153 |
0.78 |
AKT1 |
207 |
P31749 |
0.80 |
CAV1 |
857 |
Q03135 |
0.84 |
NOSIP |
51070 |
Q9Y314 |
0.86 |
NOSTRIN |
115677 |
Q8IVI9 |
0.89 |
CALM2 |
805 |
P62158 |
0.90 |
CALM3 |
808 |
P62158 |
0.90 |